コネキシン遺伝子転送は伝導速度を保ち,心房細動を予防します
Tomonori Igarashi1, J Emanuel Finet, Ayano Takeuchi
1Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio, USA.
Circulation
|December 14, 2011
まとめ
ギャップジャンクション遺伝子療法は,豚のモデルで心房伝導を改善し,心房動 (AF) を予防しました. このアプローチはコネキシンの発現を回復させ,AFの潜在的な治療戦略を提供しました.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- 心房細動 (AF) の維持は,短期の耐火期または遅れた伝導を必要とする再侵入メカニズムと関連しています.
- AFは線維症,細胞機能障害,および変化したギャップジャンクションタンパク質と関連しており,伝導の遅延につながります.
- この研究では,伝導を改善し,AFの予防におけるギャップジャンクションタンパク質過剰発現の役割を調査しました.
研究 の 目的:
- ギャップジャンクションタンパク質の過剰発現が心房伝導を高める可能性があるという仮説を検証するために.
- ギャップ・ジャンクション・遺伝子治療が心房細動の維持を防ぐことができるかどうかを判断する.
- 豚のモデルにおいて,コンネキシン (Cx) 40およびCx43の遺伝子転送が心房電気生理学に及ぼす影響を調査する.
主な方法:
- 30匹のヨークシャー豚は,副鼻腔リズムとAFグループに分けられ,サブグループには偽手術,Cx40またはCx43遺伝子治療を受けた.
- エピカルディアル遺伝子ペインティングが行われ,AFグループでは勃発性心房ペースを施した.
- 動物は遺伝子移植の7日後に研究され,トランスゲン発現と心房伝導を評価した.
主要な成果:
- AF動物では,Cx43遺伝子の移植により,コントロールと比較してコネクシン発現と細胞の局所化が回復した.
- Cx40とCx43の両方の遺伝子治療は,AF動物の心房伝導を著しく改善しました.
- コネクシン遺伝子移植は,対照群と比較して,AFの発生率と持続時間を減少させた.
結論:
- コネキシン遺伝子治療は,AFの存在において,心房伝導を効果的に保存しました.
- ギャップジャンクションタンパク質を標的とした遺伝子治療は,AFを予防する有望な戦略です.
関連する概念動画
G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
Mechanism of Cardiac Arrhythmias
2.8K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.8K
Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Conduction System of the Heart
13.7K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.7K
Regulation of Heart Rates
6.1K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.1K
Conduction System of the Heart
6.1K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
6.1K


